Biocept Inc. WKN: A2QEQE ISIN: US09072V5012 Forum: Aktien User: Auweia

SAN DIEGO--(BUSINESS WIRE)--Oct. 17, 2022-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the expanded commercial availability of CNSide for patients with metastatic melanoma. Previously validated for lung, breast, and all other carcinomas, Biocept’s CNSide is a proprietary CSF assay designed to better detect and inform treatment decisions for patients with metastatic cancers involving the central nervous system (CNS).

SAN DIEGO--(BUSINESS WIRE)--Nov. 16, 2022-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces a collaboration agreement to participate in an investigator-initiated, non-therapeutic pilot study to evaluate the cerebrospinal fluid tumor and immune cell microenvironment in patients with metastatic breast cancer and brain metastases and/or leptomeningeal disease. The study is designed to identify biomarkers associated with central nervous system (CNS) metastasis, enabling a better understanding of treatment response, prognosis, and treatment resistance that may improve the management of CNS disease in patients with metastatic breast cancer.

Zahlen da. Übel...

sieht so aus ... wobei ich nicht weiß, wie der Markt diesen Sachverhalt wertet: ... has reported a 176% year-over-year jump in orders for its CNSide product, a cerebrospinal fluid assay addressing unmet needs for patients with central nervous system metastasis. ... Nachbörslich jedenfalls eher positiv als negativ ... aber das kann man schlecht werten.

weißt du evtl. was die noch cash haben?

https://www.openpr.com/news/2749426/cell-free-dna-cf-dna-testing-market-size-soaring-at-high-cagr

Wenn die mal Zahlen liefern würden...

Umsatzerwartung dieses Jahr 48mio ... vs. 17mio market cap ...

... Applied DNA hatte das ja vor kurzem verkündet, woraufhin der Kurs explodierte. Mal schauen

ist nur eine Vermutung, aber es könnte sein, dass Biocept demnächst PCR Tests bzgl. Affenpocken anbietet

bin mal eingestiegen

Biocept Appoints Samuel D. Riccitelli as Interim President and Chief Executive Officer and Antonino Morales as Interim Chief Financial Officer

Das ist aber gute Nachrichten 👍

Biocept's CNSide Assay Identifies Tumor Cells and Actionable Treatment Biomarkers from Cerebrospinal Fluid in Patients with Metastatic Non-Small Cell Lung Cancer

Zahlen gestern raus. 12 Millionen Umsatz... 0,9 im 1Q 2020. Massive Steigerung. Kursverlauf für mich mehr als merkwürdig.